US Patent 11744878 Methods for treatment of COVID-19 syndrome
Patent 11744878 was granted and assigned to ChiRhoClin, Inc. on September, 2023 by the United States Patent and Trademark Office.
All edits
Edits on 7 Sep, 2023
Golden AI
Edits made to:
Infobox (+22 properties)
Article (+306 characters)
US Patent 11744878 Methods for treatment of COVID-19 syndrome
Article
The invention relates generally to methods for treating and modulating the severity of COVID-19 syndrome. The methods comprise administering a therapeutically effective amount of a pharmaceutical composition to a human patient, the composition comprising secretin and a pharmaceutically acceptable carrier.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
11744878
Patent Inventor Names
Edward D. Purich
Date of Patent
September 5, 2023
Patent Application Number
17389571
Date Filed
July 30, 2021
Patent Citations
Patent Primary Examiner
Find more entities like US Patent 11744878 Methods for treatment of COVID-19 syndrome
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.